Filing Flows › Puma Biotechnology (PBYI) › Net income
Puma Biotechnology (PBYI) net income by quarter
Puma Biotechnology's net income was $6.0M in Q3 2026 (third quarter 2026), -27% from Q2 2026. Over the last 6 quarters it ranged from $3.0M (Q1 2025) to $13.4M (Q4 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $6.0M | -27% | -32% |
| Q2 2026 | $8.2M | -39% | +40% |
| Q4 2025 | $13.4M | +52% | — |
| Q3 2025 | $8.8M | +51% | — |
| Q2 2025 | $5.9M | +97% | — |
| Q1 2025 | $3.0M | — | — |
Q3 2026 at a glance
Puma Biotechnology, Q3 2026: revenue $55.1M (+1% year over year), operating margin 9.6%, net earnings $6.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Puma Biotechnology's net income?
Puma Biotechnology's net income was $6.0M in Q3 2026 (third quarter 2026), -27% from Q2 2026.
How has Puma Biotechnology's net income changed?
Over the last 6 quarters it ranged from $3.0M (Q1 2025) to $13.4M (Q4 2025).